This article is more than 5 years old. Information may no longer be current.

Foundation honors St. Jude researcher

Issue: January 25, 2013

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

 

Charles Mullighan

The Meyenburg Foundation in Germany presented Charles Mullighan, MBBS(Hons), MSc, MD, with the Meyenburg Cancer Research Award.Charles Mullighan

The award recognizes scientific accomplishments in the fields of cancer research and treatment.

Mullighan is an associate member in the department of pathology at St. Jude Children’s Research Hospital. He also is co-leader of its hematologic malignancies program and medical director of the Tissue Resources Core Facility.

His research uses genomic profiling and experimental modeling to investigate the genetic basis of acute leukemia. His work has identified genetic alterations that contribute to the development of leukemia, and it also led to new diagnostic tests and therapeutic targets.

"This is an outstanding achievement and recognition for Dr. Mullighan," James R. Downing, MD, deputy director, scientific director and executive vice president at St. Jude, said in a press release. "Dr. Mullighan’s dedication to his field has helped push research from the laboratory into the clinic."